Crestwood Advisors Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-7,252
Closed -$720K 266
2019
Q3
$720K Buy
7,252
+850
+13% +$80.8K 0.03% 145
2019
Q2
$592K Buy
+6,402
New +$608K 0.03% 150
2018
Q1
Sell
-2,526
Closed -$264K 201
2017
Q4
$264K Sell
2,526
-1,265
-33% -$143K 0.02% 150
2017
Q3
$553K Sell
3,791
-440
-10% -$59.9K 0.05% 101
2017
Q2
$567K Sell
4,231
-193
-4% -$23.6K 0.05% 97
2017
Q1
$548K Buy
4,424
+2,009
+83% +$240K 0.05% 95
2016
Q4
$280K Sell
2,415
-56
-2% -$6.24K 0.03% 124
2016
Q3
$258K Sell
2,471
-830
-25% -$89.8K 0.03% 112
2016
Q2
$326K Sell
3,301
-350
-10% -$36.2K 0.04% 102
2016
Q1
$365K Sell
3,651
-55
-1% -$5.66K 0.04% 100
2015
Q4
$444K Sell
3,706
-156
-4% -$18K 0.05% 101
2015
Q3
$418K Sell
3,862
-500
-11% -$62K 0.05% 91
2015
Q2
$505K Sell
4,362
-235
-5% -$26.9K 0.07% 89
2015
Q1
$530K Buy
4,597
+2,307
+101% +$276K 0.08% 77
2014
Q4
$256K Buy
+2,290
New +$242K 0.04% 114

Other funds holding CELG

Crestwood Advisors Group's CELG Position: Q4 2019 in Review

Crestwood Advisors Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,252 shares — an estimated $720K sold.

Crestwood Advisors Group first reported a position in CELG in Q4 2014 and held it in 15 quarters. The position peaked at $720K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Crestwood Advisors Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Crestwood Advisors Group sold 7,252 Celgene Corp shares in Q4 2019, an estimated $720K.
  • Crestwood Advisors Group first reported a position in Celgene Corp in Q4 2014 and held it in 15 quarters.
  • Crestwood Advisors Group's Celgene Corp position peaked at $720K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Crestwood Advisors Group's 13F filing for Q4 2019, filed 12 Feb 2020.